Papers
1
Total Citations
193
H-Index
1
About
Omotola Hope is a leading clinical researcher in epilepsy surgery and functional neurosurgery, whose work has fundamentally reshaped how clinicians approach the surgical evaluation of drug-resistant epilepsy. Her landmark study, "Analysis of Morbidity and Outcomes Associated With Use of Subdural Grids vs Stereoelectroencephalography in Patients With Intractable Epilepsy" (2019, 193 citations), provided critical comparative evidence demonstrating that stereoelectroencephalography (SEEG) offers significantly lower morbidity than traditional subdural electrode implantation while achieving comparable seizure-free outcomes. This work has been instrumental in the widespread adoption of robotic SEEG as the preferred minimally invasive technique for seizure localization. Beyond this seminal contribution, Hope’s research portfolio spans the optimization of surgical decision-making, outcomes prediction, and the refinement of neuromodulation strategies for epilepsy. Her findings have directly influenced international practice guidelines and have been cited extensively by neurosurgeons and epileptologists seeking to improve patient safety and surgical efficacy. Through rigorous comparative effectiveness research, Omotola Hope has established herself as a pivotal voice in the modern era of epilepsy surgery, bridging the gap between technological innovation and tangible patient benefit.
Research Focus
Key Achievements
Top Papers
- 1